Xingliang Tan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Antibody-drug conjugate-related marker heterogeneity between primary tumors and metastatic lymph nodes in advanced urothelial cancers.
Journal: Journal of translational internal medicine
Published: July 02, 2026
Disulfidptosis in cancer: from redox stress to therapeutic strategy.
Journal: Cancer gene therapy
Published: September 28, 2025
DCLK1 drives malignant progression and chemoresistance of bladder cancer by deubiquitinating HDAC6.
Journal: Molecular cancer
Published: September 12, 2025
Global, regional, and national bladder cancer burden from 1990 to 2021 and forecasts to 2050: a systematic analysis of the global disease burden study in 2021.
Journal: BMC public health
Published: June 18, 2025
NSUN2-mediated m5C modification of SOCS3 mRNA modulates macrophage polarization in bladder cancer.
Journal: Cell death & disease
Published: May 28, 2025
TROP-2 Promotes Cell Proliferation via the AKT-Mediated PKCα Pathway and Is a Novel Target for Antibody-Drug Conjugates in Penile Carcinoma.
Journal: Oncology research
Published: March 31, 2025
An Evaluation of HER2 Expression Heterogeneity in Primary Tumors and Metastatic Lymph Nodes of Patients With Advanced Extramammary Paget's Disease: Prognostic and Therapeutic Implications.
Journal: Cancer medicine
Published: March 18, 2025
Neutrophil-to-lymphocyte ratio predicts a poor prognosis for penile cancer with an immunosuppressive tumor microenvironment.
Journal: Frontiers in immunology
Published: January 30, 2025
Clinical Effectiveness of Tislelizumab With Gemcitabine/Cisplatin Versus Gemcitabine/Cisplatin Alone as Adjuvant Therapy for High-Risk Muscle-Invasive Urothelial Carcinoma: A Real-World Study.
Journal: Cancer medicine
Published: October 24, 2024
Last Updated: 09/26/2026